文献速递慢性肾脏病肾血管病与高血压

盐皮质激素受体激活与FGF23-Klotho级联的交叉:促进肾心损伤的双重驱动

The intersection of mineralocorticoid receptor activation and the FGF23-Klotho cascade: a duopoly that promotes renal and cardiovascular injury.
PubMed 文献 · Nephrol Dial Transplant · 2022-01-01

综述探讨慢性肾脏病(CKD)中心血管疾病(CVD)高发的机制,聚焦矿物质代谢紊乱相关因子FGF23与可溶性Klotho。文章分析FGF23升高、盐皮质激素受体(MR)激活及Klotho降低如何通过互补途径相互放大对肾脏和心脏的损害,促进CKD与心功能障碍的发生发展。

要点

  • CKD患者CVD高发,矿物质代谢紊乱是特有危险因素。
  • FGF23升高直接促心肌肥厚,Klotho降低则加剧纤维化与血管钙化。
  • MR激活与FGF23升高、Klotho降低协同放大肾心损伤。

核心结论

  • CKD中FGF23升高、MR激活与循环Klotho降低可能相互增强对肾脏和心脏的有害效应。

研究设计与样本

  • 综述,未报告系统检索范围与样本量。

主要发现

  • 循环Klotho水平降低及肾脏Klotho表达受抑可能与CKD患者不良结局相关。
  • 心脏局部产生或循环升高的FGF23对心肌发挥促肥厚机制。
  • Klotho可减轻组织纤维化、CKD进展、心肌病、内皮功能障碍、血管僵硬和血管钙化。
  • CKD中由醛固酮等配体介导的非经典靶点MR激活放大CVD。

临床怎么用

  • 应关注CKD患者FGF23、Klotho及MR激活状态对肾心风险的联合影响。

局限性

  • 为综述性论述,未提供原始研究数据或定量合并结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The nexus of chronic kidney disease (CKD) and cardiovascular disease (CVD) amplifies the morbidity and mortality of CKD, emphasizing the need for defining and establishing therapeutic initiatives to modify and abrogate the progression of CKD and concomitant CV risks. In addition to the traditional CV risk factors, disturbances of mineral metabolism are specific risk factors that contribute to the excessive CV mortality in patients with CKD. These risk factors include dysregulations of circulating factors that modulate phosphate metabolism, including fibroblast growth factor 23 (FGF23) and soluble Klotho. Reduced circulating levels and suppressed renal Klotho expression may be associated with adverse outcomes in CKD patients. While elevated circulating concentrations or locally produced FGF23 in the strained heart exert prohypertrophic mechanisms on the myocardium, Klotho attenuates tissue fibrosis, progression of CKD, cardiomyopathy, endothelial dysfunction, vascular stiffness and vascular calcification. Mineralocorticoid receptor (MR) activation in nonclassical targets, mediated by aldosterone and other ligands, amplifies CVD in CKD. In concert, we detail how the interplay of elevated FGF23, activation of the MR and concomitant reductions of circulating Klotho in CKD may potentiate each other's deleterious effects on the kidney and heart, thereby contributing to the initiation and progression of kidney and cardiac functional deterioration, acting through multipronged, albeit complementary, mechanistic pathways.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Epstein M, Freundlich M. The intersection of mineralocorticoid receptor activation and the FGF23-Klotho cascade: a duopoly that promotes renal and cardiovascular injury. Nephrol Dial Transplant. 2022. PMID: 34459924. doi:10.1093/ndt/gfab254

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。